UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042599
Receipt number R000048622
Scientific Title Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers
Date of disclosure of the study information 2020/12/01
Last modified on 2020/11/30 17:50:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers

Acronym

Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers

Scientific Title

Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers

Scientific Title:Acronym

Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers

Region

Japan


Condition

Condition

COVID-19

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the risk of COVID-19 among pediatric health care workers and its relationship to subclinical infection and national epidemiology.

Basic objectives2

Others

Basic objectives -Others

Evaluate SARS-CoV-2 serum antibody titers in pediatric health care workers, symptoms during the observation period, and contact and morbidity with COVID-19 patients.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of COVID-19 among pediatric health care workers during the study period

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Blood examinations will be performed 3 times.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Members of the Department of Pediatrics, St. Marianna University School of Medicine, who fully understand and consent to this research project will be eligible for the study.

Key exclusion criteria

If consent cannot be obtained, the person will not be considered eligible.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yukitsugu
Middle name
Last name Nakamura

Organization

St. Marianna University School of Medicine

Division name

Department of Pediatrics

Zip code

216-8511

Address

2-16-1 Sugao, Miyamae-ku Kawasaki, Kanagawa

TEL

044-977-8111

Email

y2nakamura@marianna-u.ac.jp


Public contact

Name of contact person

1st name Yukitsugu
Middle name
Last name Nakamura

Organization

St. Marianna University School of Medicine

Division name

Department of Pediatrics

Zip code

216-851

Address

2-16-1 Sugao, Miyamae-ku Kawasaki, Kanagawa

TEL

044-977-8111

Homepage URL


Email

y2nakamura@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna University School of Medicine

Address

2-16-1 Sugao, Miyamae-ku Kawasaki, Kanagawa

Tel

044-977-8111

Email

y2nakamura@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2020 Year 12 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 11 Month 30 Day

Last modified on

2020 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048622


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name